Does group insurance cover Ozempic, Wegovy and Mounjaro in Canada?

    Does group insurance cover Ozempic, Wegovy and Mounjaro in Canada?

    Many group insurance plans in Canada cover Ozempic and Mounjaro, usually when they're prescribed for Type 2 diabetes. Coverage for Wegovy and Zepbound depends on each plan's drug list, and weight-loss coverage is uncommon. Public drug programs only help specific groups, and the rules vary by province. A Leger survey estimates that almost 3 million Canadian adults take a GLP-1. Generic semaglutide began appearing in Canadian pharmacies in 2026, at reported prices of about $100 a month. Here's what HR leaders and founders need to know about coverage, costs and supporting employees already on treatment.

    In short

    • Many group plans cover GLP-1s for Type 2 diabetes. Coverage for weight loss is uncommon.
    • Insurers often check claims before paying. Two common approaches are prior authorization and step therapy.
    • Generic semaglutide for Type 2 diabetes (generic Ozempic) is reported at about $100 a month, depending on dose and pharmacy.
    • On Alan's standard plans, Ozempic and Mounjaro are covered for Type 2 diabetes through step therapy. Employees switching from another insurer can send proof of their treatment before their coverage starts.
    • Weight-loss coverage can be added on a custom plan, at a different price.

    Does insurance cover Ozempic in Canada?

    Often, yes, when it's prescribed for Type 2 diabetes. Health Canada approved Ozempic and Mounjaro to treat Type 2 diabetes, and many private drug plans reimburse them for that use. When Ozempic is prescribed "off-label" for weight loss, some group plans refuse the claim. Coverage for Wegovy and Zepbound depends on the plan's drug list, the approved use and any authorization rules.

    Why the diagnosis decides coverage

    GLP-1s copy a hormone that helps control blood sugar and slows digestion. Several brands contain the same or similar molecules, but each one is approved for specific uses. Many insurers base their coverage on those approvals.

    DrugMoleculeMain approved use in CanadaGroup coverage
    OzempicSemaglutideType 2 diabetesOften covered for Type 2 diabetes
    Generic semaglutide (generic Ozempic)SemaglutideType 2 diabetesMay be covered if the plan includes it. With generic substitution, Ozempic may be reimbursed at the generic price.
    MounjaroTirzepatideType 2 diabetesOften covered for Type 2 diabetes
    WegovySemaglutide (higher dose)Chronic weight managementDepends on the plan's drug list and the approved use
    Sevmia (generic Wegovy)Semaglutide (higher dose)Chronic weight managementDepends on the plan's drug list and the approved use
    ZepboundTirzepatideChronic weight management, and obstructive sleep apnea in adults with obesityDepends on the plan's drug list and the approved use

    Every plan is different, so the best way to know what's covered is to check your own plan's drug list.

    What do public drug plans cover in Ontario?

    Public drug coverage varies by province and territory. In Ontario, Ozempic has been a Limited Use benefit on the Ontario Drug Benefit (ODB) since January 31, 2024. Eligible ODB recipients can get it covered if they have Type 2 diabetes and meet the Limited Use criteria.

    The ODB program mainly covers:

    • people aged 65 and over
    • people aged 24 and under who aren't covered by a private plan (OHIP+)
    • people on social assistance or in some care settings
    • people enrolled in the Trillium Drug Program, which helps when drug costs are high compared to household income

    Across Canada, Canada's Drug Agency (CDA-AMC) notes that most public drug plans don't fund drugs for chronic weight management.

    What this means for employers: children aged 24 and under can't get OHIP+ while they're covered by a private plan. Employees who don't qualify for a public drug program may rely mainly on their group plan.

    How do private insurers manage GLP-1 claims?

    Because GLP-1s are expensive and widely used, insurers often add a check before paying. Two common approaches are prior authorization and step therapy.

    Prior authorization

    The member and their doctor fill in a form that explains the diagnosis and past treatments. The insurer reviews it before approving the drug. Some large Canadian insurers use prior authorization for Ozempic. For the employee, this means paperwork, a doctor's visit and a wait before the first claim goes through.

    Step therapy

    The insurer checks whether the member has already tried a first-line drug for Type 2 diabetes, such as Metformin. Under some step therapy programs, the claim can be approved automatically once the member has met this requirement. Each insurer has its own process.

    How much do GLP-1s cost without coverage in 2026?

    Prices have dropped a lot this year. On April 28, 2026, Canada became the first G7 country to approve a generic version of semaglutide. By late May, Canadian pharmacies were reporting prices of about $100 a month for generic semaglutide for Type 2 diabetes. Prices and stock vary by dose, pharmacy and supply. Several generic makers have been approved since then.

    Novo Nordisk Canada offers a savings card that brings brand-name Ozempic close to the generic price for eligible patients, including some people with private drug plans. It isn't available in Quebec.

    Other GLP-1s still cost more. Before generics arrived, list prices for brand-name GLP-1s in Canada were reported at about $200 to $400 a month, depending on the drug and the dose.

    Cost is still a barrier. In a February 2026 Leger survey, about a quarter of respondents taking a GLP-1 said they paid for it entirely out of pocket.

    How does Alan cover GLP-1s?

    Alan's standard plans cover GLP-1s for Type 2 diabetes like any other prescription drug, with step therapy managed through TELUS Health. Alan covers prescription drugs that have a Health Canada DIN (drug identification number), are prescribed by a licensed doctor or practitioner, and are dispensed by a pharmacist.

    What's covered and what isn't

    SituationCovered on Alan's standard plans?
    Ozempic, generic semaglutide or Mounjaro for Type 2 diabetesYes, through step therapy
    GLP-1s for weight lossNo
    GLP-1s for Type 1 diabetes or PCOSNo
    Wegovy, Sevmia or ZepboundNo

    How step therapy works at Alan

    1. Your employee already claimed a first-line diabetes drug, such as Metformin, with Alan. Under Alan's step therapy process, the GLP-1 claim is approved automatically at the pharmacy. Nothing else to do.
    2. They have no claim history with Alan. They can send proof of first-line treatment in the Alan app for review. This can be a doctor's note, a past prescription or their pharmacy claims history.
    3. They can't show proof of past treatment. In this case, the claim is declined at first. They can send documentation from their doctor, such as a doctor's note, or go through Alan's step therapy program.

    How much is reimbursed

    GLP-1s count toward the same yearly prescription drug limit as other covered drugs.

    Alan planReimbursementYearly drug limit
    Bear80%Up to $3,000
    Marmot100%Up to $10,000
    Caribou80%Up to $100,000
    Bison100%Up to $100,000

    In Quebec, group plans must cover at least the drugs on the public RAMQ list, and provincial rules limit how much members pay for them each year. This means Quebec residents have unlimited coverage for drugs on the RAMQ list on every Alan plan, including Bear, Marmot and custom plans.

    For example, for an employee outside Quebec: generic semaglutide at about $100 a month comes to about $1,200 a year. On the Bear plan, Alan would reimburse 80%, or about $960, which leaves plenty of room under the $3,000 limit. A brand-name drug at an example price of $350 a month comes to $4,200 a year. At 80%, reimbursement would reach the $3,000 limit before the end of the year. For employees who need brand-name drugs long term, a plan with a higher limit can make a real difference.

    Generic substitution

    Alan's plans use generic substitution. Now that generic semaglutide is available, Ozempic is reimbursed up to the price of the generic. Employees are usually asked to try the generic first. If they can't use it, for example because of adverse side effects, their doctor can send a full note explaining why, and Alan will review the claim for the brand-name drug. Otherwise, the employee pays the difference.

    Employees already on a GLP-1 when you switch to Alan

    This is often what worries employees most when their company changes insurer: will their treatment stop?

    With Alan, employees already taking a GLP-1 for Type 2 diabetes can send proof of past treatment in the app before their coverage starts. This can be a doctor's note, a prescription, pharmacy records or claims history from their previous insurer. Alan sends it to TELUS Health on the first day of coverage. Approval is usually quick, though timing can vary.

    Good to know

    For a drug claim of $500 or more, it's a good idea to send a quote in the Alan app before buying. It's not required, but it helps confirm how much will be reimbursed.

    Want to see the full drug coverage on each plan? Explore Alan's health insurance plans in Canada.

    Should your company cover GLP-1s for weight loss?

    That's up to you. Alan's standard plans don't cover GLP-1s for weight loss. On a custom plan, employers can add weight-loss coverage or exclude GLP-1s altogether. Both choices change the price of the plan.

    Here are a few questions to ask before you decide:

    • Can your budget handle it? In a 2026 survey of 105 large US employers by Business Group on Health, 72% of those covering GLP-1s for weight management said they were likely to continue that coverage in 2027. These figures are from the US and aren't a forecast for Canada.
    • How much do your employees care? In the Leger survey, more than half of Canadians with current, past or possible future interest in a GLP-1 said insurance coverage or a lower-cost generic would make them more likely to use one. For a small tech company competing for talent, a benefit like this can stand out.
    • What do generics change? Generic semaglutide is now approved in Canada for Type 2 diabetes and chronic weight management. Health Canada approved Apotex's Sevmia, the first generic version of Wegovy, in June 2026. Zepbound is still brand-name only. Sevmia is approved for weight management, so it isn't covered on Alan's standard plans.
    • What other support does your plan offer? Alan's standard plans cover dietitians up to $500 a year (80% on Bear and Caribou, 100% on Marmot and Bison). That gives employees another form of weight-management support, whether or not they take medication.

    If you run a small team, see how Alan builds group benefits for small businesses, or check pricing to compare plans.

    Looking for group benefits that are clear about what they cover? Get a quote or book a demo to see how Alan works for your team.

    Frequently asked questions

    Covered dependants generally follow the same drug rules and yearly limits as the employee, subject to the plan's eligibility and coordination rules.

    It can be. Alan covers prescription drugs that have a Health Canada DIN, are prescribed by a licensed doctor or practitioner, and are dispensed by a pharmacist. A virtual clinic prescription can qualify if it meets these criteria. The coverage rules for Type 2 diabetes still apply. Health Canada has warned about fake or unauthorized GLP-1 products sold online. Products from unauthorized sources can be unsafe and aren't eligible under Alan's plans.

    No. As of November 2026, no generic version of Mounjaro or Zepbound has been approved in Canada. Generic semaglutide, the molecule in Ozempic and Wegovy, is approved for Type 2 diabetes and chronic weight management.

    Some prescription drug costs that weren't reimbursed may qualify for the federal medical expense tax credit, if the CRA's requirements are met. Employees should keep their prescription and receipts, and check with the CRA or a tax professional.

    Updated on 18/11/2026

    Published on 16/11/2026

    Updated on

    18 November 2026

    Share the article

    The best digital health insurance

    Get started with Alan now

    Discover AlanDiscover Alan